Creating a Data Strategy and Enablement Framework for Life Sciences – IQVIA
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks–GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
Browse our library of insights and thought leadership.
Visit our library of on-demand webinars.
View our upcoming events and webinars.
Top Issues for Pharma to Watch in 2022 and 2023
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks–GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
“Browse our library of insights and thought leadership.
Visit our library of on-demand webinars.
View our upcoming events and webinars.
“Top Issues for Pharma to Watch in 2022 and 2023
Share PAGE
Traditional IT systems and processes can no longer meet the expectations of life science organizations given the growth of information sources, nuanced engagement models, and myriad of stakeholders to manage.
There is also a clear consensus on the need to engage seamlessly across an evolving ecosystem of digital, personal, and 3rd-party channels to connect various artifacts of data. This is not a mere tactical business operation, but an actual value-driven activity to realize uncapped business value and drive actionable insights for the business. From supporting scientific innovation to designing new commercial model designs, life science businesses are using a use-case-driven approach to define the right data strategy. Having supported 20+ customers with different maturity indexes of data strategy, the IQVIA team has grouped data strategy success metrics into the following categories:
Going forward, life science organizations will need to follow a rational and logical business plan to create a strong enterprise grade data strategy that helps unlock the true value of data and supports an optimized data to insights journey. IQVIA supports life science companies by defining and execute their data-strategy and can partner across all aspects of the information management framework.
Transform data into action
This article was autogenerated from a news feed from CDO TIMES selected high quality news and research sources. There was no editorial review conducted beyond that by CDO TIMES staff. Need help with any of the topics in our articles? Schedule your free CDO TIMES Tech Navigator call today to stay ahead of the curve and gain insider advantages to propel your business!
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks–GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
Browse our library of insights and thought leadership.
Visit our library of on-demand webinars.
View our upcoming events and webinars.
Top Issues for Pharma to Watch in 2022 and 2023
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks–GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
“Browse our library of insights and thought leadership.
Visit our library of on-demand webinars.
View our upcoming events and webinars.
“Top Issues for Pharma to Watch in 2022 and 2023
Share PAGE
Traditional IT systems and processes can no longer meet the expectations of life science organizations given the growth of information sources, nuanced engagement models, and myriad of stakeholders to manage.
There is also a clear consensus on the need to engage seamlessly across an evolving ecosystem of digital, personal, and 3rd-party channels to connect various artifacts of data. This is not a mere tactical business operation, but an actual value-driven activity to realize uncapped business value and drive actionable insights for the business. From supporting scientific innovation to designing new commercial model designs, life science businesses are using a use-case-driven approach to define the right data strategy. Having supported 20+ customers with different maturity indexes of data strategy, the IQVIA team has grouped data strategy success metrics into the following categories:
Going forward, life science organizations will need to follow a rational and logical business plan to create a strong enterprise grade data strategy that helps unlock the true value of data and supports an optimized data to insights journey. IQVIA supports life science companies by defining and execute their data-strategy and can partner across all aspects of the information management framework.
Transform data into action
This article was autogenerated from a news feed from CDO TIMES selected high quality news and research sources. There was no editorial review conducted beyond that by CDO TIMES staff. Need help with any of the topics in our articles? Schedule your free CDO TIMES Tech Navigator call today to stay ahead of the curve and gain insider advantages to propel your business!
